Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT01577745 |
| Title | A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | MedImmune LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Research Site | Los Angeles | California | 90404 | United States | Details | |
| Research Site | New Haven | Connecticut | 06513 | United States | Details | |
| Research Site | Boston | Massachusetts | United States | Details | ||
| Research Site | Ann Arbor | Michigan | 48103 | United States | Details | |
| Research Site | Minneapolis | Minnesota | United States | Details | ||
| Research Site | New York | New York | 10002 | United States | Details | |
| Research Site | Cincinnati | Ohio | 45201 | United States | Details | |
| Research Site | Cleveland | Ohio | 44105 | United States | Details | |
| Research Site | Houston | Texas | 77030 | United States | Details | |
| Research Site | Seattle | Washington | 98112 | United States | Details | |
| Research Site | Tacoma | Washington | 98405 | United States | Details |